Overview:
The fructosamine test measures the average blood glucose levels over the past 2 to 3 weeks. Unlike the HbA1c test, which gives a long-term picture of blood sugar control over about 2 to 3 months, the fructosamine test provides a shorter-term view. It is useful in monitoring diabetes and evaluating how well blood sugar is being managed in the short term, especially in situations where HbA1c levels might be misleading, such as in patients with anemia or those with conditions affecting red blood cells.

Risk Assessment:

• Diabetes Monitoring: The fructosamine test helps in assessing diabetes control in people with diabetes, particularly when the HbA1c test may not provide accurate results.
• Glycemic Control Evaluation: It helps determine the effectiveness of treatment plans and dietary modifications.
• Conditions Impacting Red Blood Cells: It can be an alternative in patients with conditions like anemia or hemoglobinopathies, where HbA1c might be less reliable.

The typical reference range for fructosamine levels is around 200 to 285 µmol/L, but it can vary depending on the laboratory and individual circumstances. The range can also be adjusted based on age, health conditions, and the testing method used.

Interpretation:

• High fructosamine levels may suggest poor blood sugar control, similar to high HbA1c levels.
• Low fructosamine levels could indicate good blood sugar control.
• The test reflects blood glucose levels over the past 2 to 3 weeks, so fluctuations can be observed if recent lifestyle changes or treatment modifications occurred.

The test requires a blood sample, typically drawn from a vein in the arm, though a fingerstick sample may sometimes be used.